Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Eliquis3B25.24%
Opdivo2.36B19.85%
Other1.47B12.38%
Revlimid1.41B11.87%
Orencia936M7.87%
Pomalyst/Imnovid898M7.55%
Yervoy642M5.40%
Reblozyl447M3.76%
Other Growth products433M3.64%
Sprycel290M2.44%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States31.56B70.11%
International12.75B28.33%
Other699M1.55%
